The Bharat Cancer Genome Atlas (BCGA) is a new resource from the Indian Institute of Technology Madras (IIT Madras), aimed at revolutionizing cancer research in India. Launched on World Cancer Day (February 4), this public database is accessible to researchers and healthcare providers through bcga.iitm.ac.in.
This initiative addresses a key gap: India has been largely unrepresented in global genomic studies of cancer. This under-representation has hindered the development of treatments tailored to the Indian population. The BCGA currently holds important genomic data for pediatric leukemia, colorectal cancer, and pancreatic cancer, which are significant health issues in the country.
IIT Madras highlights that nearly one in nine Indians is likely to develop cancer in their lifetime, according to the Indian Council of Medical Research (ICMR). The National Cancer Registry Programme reports a troubling 12.8% annual rise in cancer cases since 2022, with around 2.5 million people living with cancer in India today.
The BCGA’s primary objective is to collect genetic variants relevant to these cancers facing the Indian community. Prof. V. Kamakoti, Director of IIT Madras, emphasizes that this atlas will help achieve early diagnosis and better treatment decisions, contributing to improved health outcomes overall.
Prof. S. Mahalingam, from the Hyundai Centre for Cancer Genomics at IIT Madras, adds that the lack of detailed genomic information has hampered the creation of targeted diagnostic kits and therapies. The BCGA seeks to change this by identifying cancer-specific biomarkers that are particularly relevant to Indian patients.
This project is not just about data. It represents a collaborative effort with organizations like Karkinos Healthcare and KK Childs Trust Hospital. Hyundai is contributing to this mission through a generous funding boost of Rs 56 crore, aimed not only at genomic research but also at assisting low-income families affected by cancer and deploying mobile medical units in underserved areas.
These efforts signify a forward step in addressing cancer treatment disparities in India while aligning local research with global standards. As more data becomes available through the BCGA, it is expected to shape future cancer care practices in the country.
For more information on cancer statistics in India, you can refer to the latest ICMR reports here. Stay informed about developments in cancer research and health initiatives.
